The memo, issued by the department of expenditure under finance
ministry, advised ministries that "disruption of supply chain due to
spread of Covid-19 in China, or any other country, would be considered
as a case of natural calamity and force majeure clause may be invoked
in appropriate cases".
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-impact-govt-wont-penalise-companies-hit-by-supply-shortages/articleshow/74218305.cms
No comments:
Post a Comment